| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Ida Rahmi Kurniasih CEO | IDX Exchange | ID1000147507 ISIN |
| Indonesia Country | 1,264 Employees | 19 Jun 2023 Last Dividend | - Last Split | - IPO Date |
Founded in 1954 and headquartered in Jakarta, Indonesia, PT Phapros, Tbk is a prominent player in the pharmaceutical and healthcare industry. Operating through its subsidiaries, the company has carved out a significant presence in the Indonesian market, offering a wide range of products across various segments. PT Phapros operates through four main segments: Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing; and Toll-in Manufacturing. A subsidiary of PT Kimia Farma (Persero) Tbk, PT Phapros, Tbk not only serves the domestic market but also exports its products, demonstrating its global outreach and reputation in the pharmaceutical industry.
PT Phapros offers a variety of OTC drugs catering to various health needs. This range includes popular products such as Antimo Anak, Livron B Plek, Noza, Hemorogard, and Bioron. These products are designed for ease of access and self-care, allowing consumers to address minor health issues without the need for a prescription.
The company provides a wide array of generic drug products primarily for government institutions and hospitals. These generic drugs are crucial in ensuring the accessibility and affordability of essential medications to the larger public, particularly in the healthcare system. By supplying these products, PT Phapros plays a vital role in supporting public health initiatives.
In addition to its own product lines, PT Phapros also engages in toll-in manufacturing. This segment involves the production of drugs for other pharmaceutical industries, showcasing the company’s flexibility and capacity to meet various manufacturing needs. Through toll-in manufacturing, PT Phapros extends its services beyond its own brand, supporting other enterprises within the pharmaceutical industry.
Expanding its healthcare focus, PT Phapros also offers medical devices. This diversification into medical equipment further strengthens the company’s portfolio in healthcare, providing comprehensive solutions that address the needs of healthcare providers and patients alike.